» Articles » PMID: 35538531

What Can Be Done to Improve Polycystic Ovary Syndrome (PCOS) Healthcare? Insights from Semi-structured Interviews with Women in Canada

Overview
Publisher Biomed Central
Date 2022 May 10
PMID 35538531
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Polycystic ovary syndrome (PCOS) is a common and perplexing condition affecting metabolic, reproductive, cardiovascular, and psychological health in women. Previous studies point to widespread dissatisfaction and frustration in women with the information and care they receive. Studies have found delays with the diagnosis of PCOS and gaps in knowledge in physicians regarding the diagnosis and management of PCOS. Little has been heard from women on what they think can be improved with PCOS care, especially in Canada. This qualitative study explores women's experiences navigating the healthcare system and their insights on what could be improved based on their lived experiences.

Methods: Twenty-five participants were interviewed remotely over the phone by the first author between October and December 2018.Interviews were semi-structured and in-depth. Data were analyzed using thematic analysis and interpretive description methodology.

Results: Twenty-five in-depth interviews conducted with participants across Canada (ages 18-63) revealed three overall areas in need of improvement. First, women emphasized a need for greater knowledge and awareness of PCOS in primary care physicians (PCPs) as well as the need for the medical community to prioritize women's health. Second, participants advocated for greater PCOS awareness and de-stigmatization in the general community and in women and girls, and any individuals with female reproductive systems. Third, participants brought up several needed resources, such as the need for more PCOS research to be funded and undertaken, more PCOS specialists and experts to be available, credible doctor-provided information (e.g., pamphlets, websites), and age-specific support groups and mental health supports to be available. Participants were generally unaware of existing PCOS organizations and brought up the need for established PCOS organizations to aid in the training and retraining of doctors and local awareness-building in communities.

Conclusions: Participants believed that PCPs in Canada needed to be well-versed on how to diagnose and manage PCOS to prevent delays in diagnosis and provide easier access to care. Further, greater awareness and de-stigmatization in the general community are needed so women can identify symptoms early and have access to support from those around them. Overall, PCOS may be an overlooked and under-prioritized condition, both in the Canadian healthcare system and general community.

Citing Articles

The Impact of the COVID-19 Pandemic on Health and Health Care Experience in Those With Polycystic Ovary Syndrome.

Sydora B, Wilke M, Ghosh M, Vine D Int J Womens Health. 2025; 17:287-298.

PMID: 39925784 PMC: 11806697. DOI: 10.2147/IJWH.S504439.


COVID-19 and persistent symptoms: implications for polycystic ovary syndrome and its management.

Zhang S, Wu Y, Mprah R, Wang M Front Endocrinol (Lausanne). 2024; 15:1434331.

PMID: 39429741 PMC: 11486749. DOI: 10.3389/fendo.2024.1434331.


Lack of adequate counseling about pregnancy complications in patients with polycystic ovary syndrome: a cross-sectional survey study.

Kim A, Lee I, Ottey S, Dokras A F S Rep. 2024; 5(3):312-319.

PMID: 39381657 PMC: 11456671. DOI: 10.1016/j.xfre.2024.05.004.


Polycystic Ovary Syndrome and the Internet of Things: A Scoping Review.

Graca S, Alloh F, Lagojda L, Dallaway A, Kyrou I, Randeva H Healthcare (Basel). 2024; 12(16).

PMID: 39201229 PMC: 11354210. DOI: 10.3390/healthcare12161671.


Polycystic ovary syndrome and chronic pain among females and individuals of childbearing age: A scoping review.

Sacca L, Okwaraji G, Densley S, Marciniak A, Knecht M, Wilson C SAGE Open Med. 2024; 12:20503121241262158.

PMID: 38903491 PMC: 11189018. DOI: 10.1177/20503121241262158.


References
1.
Weiss T, Bulmer S . Young women's experiences living with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs. 2011; 40(6):709-18. DOI: 10.1111/j.1552-6909.2011.01299.x. View

2.
Carron R, Kooienga S, Gilman-Kehrer E, Alvero R . Cultural Experiences, Patterns, and Practices of American Indian Women With Polycystic Ovary Syndrome: An Ethnonursing Study. J Transcult Nurs. 2019; 31(2):162-170. DOI: 10.1177/1043659619856670. View

3.
Jeanes Y, Reeves S . Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges. Nutr Res Rev. 2017; 30(1):97-105. DOI: 10.1017/S0954422416000287. View

4.
Ramezani Tehrani F, Behboudi-Gandevani S, Yarandi R, Saei Ghare Naz M, Carmina E . Prevalence of acne vulgaris among women with polycystic ovary syndrome: a systemic review and meta-analysis. Gynecol Endocrinol. 2020; 37(5):392-405. DOI: 10.1080/09513590.2020.1859474. View

5.
Ee C, Smith C, Moran L, MacMillan F, Costello M, Baylock B . "The whole package deal": experiences of overweight/obese women living with polycystic ovary syndrome. BMC Womens Health. 2020; 20(1):221. PMC: 7532653. DOI: 10.1186/s12905-020-01090-7. View